• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO 2.25/18; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO 2.25/18; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 364487
Device Problem Device Dislodged or Dislocated (2923)
Patient Problem No Information (3190)
Event Date 03/11/2019
Event Type  malfunction  
Event Description
Ous mdr - it was intended to treat a coronary total occlusion (cto) in a tortuous left coronary vessel.During the procedure the stent dislodged and was finally adapted to the vessel wall with another balloon.It should be noted that, according to the ifu, the safety and effectiveness of orsiro have not yet been established in patients with cto.The hospitalization was prolonged 3 days.The physician wanted to monitor flow rates and adjust the medical dose.
 
Manufacturer Narrative
The device was not returned to biotronik.Therefore no technical investigation on the subject could be performed.The manufacturing history was reviewed to establish whether a deviation from the manufacturing process could be the cause for the reported event.Review of the manufacturing history of the product detailed above did not reveal any non-conformity.During final inspection, every stent system undergoes visual inspection to ensure correct stent embedding and homogeneous crimping of the stent.Further, the stent outer diameter is verified to 100 percent and the stent retention force of a defined amount of samples is tested from every lot.The device in question was manufactured according to specifications and successfully passed all in process controls as well as the final inspection.Based on the conducted investigations no manufacturing related root cause was determined.The final root cause for the reported event could not be identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORSIRO 2.25/18
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BIOTRONIK AG, BUELACH, SWITZERLAND
ackerstrasse 6
buelach CH-81 80
CH  CH-8180
MDR Report Key8480707
MDR Text Key140876321
Report Number1028232-2019-01345
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier07640130439023
UDI-Public7640130439023
Combination Product (y/n)N
PMA/PMN Number
P170030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 03/20/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/03/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/12/2020
Device Model Number364487
Device Catalogue NumberSEE MODEL NO.
Device Lot Number07181501
Was Device Available for Evaluation? No
Date Manufacturer Received05/08/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
-
-